[1]
Giri, R., Naresh, A., Kushwaha, J.S., Kumar, B., Verma, R.K. and Khan, M.I. 2019. Anti-albuminuric effects of spironolactone and its effect along with ramipril in type-2 diabetic nephropathy. International Journal of Advances in Medicine. 6, 1 (Jan. 2019), 140–145. DOI:https://doi.org/10.18203/2349-3933.ijam20190120.